Sanofi SNY announced that the European Commission (“EC”) has granted marketing authorization to expand the use of its multiple myeloma (MM) drug, Sarclisa (isatuximab). With this nod, Sarclisa is now ...

The company's multiple myeloma franchise, which includes Carvykti, stands to contribute significantly to its growth in 2025.

Keep yourself safe from phishing attacks, hackers and malware with the best antivirus software. Here are CNET's top picks for web protection, malware detection and more. Dianna Gunn built her ...